Sakar Healthcare

{
  "main_header": {
    "sid": 1002668,
    "name": "Sakar Healthcare",
    "stock_name": "Sakar Healthcare",
    "full_name": "Sakar Healthcare Ltd",
    "name_url": "stocks-analysis/sakar-healthcare",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "909.55",
    "chg": -15.1,
    "chgp": "-1.63%",
    "dir": -1,
    "prev_price": "924.65",
    "mcapval": "2,023.74 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "SAKAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE732S01012",
    "curr_date": "Aug 10, 12:48 PM",
    "curr_time": "13:05 PM",
    "last_traded_at": "Aug 10, 12:48 PM IST",
    "bse_nse_vol": 125334,
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sakar-healthcare-1002668-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sakar-healthcare-1002668-1&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Sakar Healthcare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4137105",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SakarHealthcare_technicaldot_4137105.png",
        "date": "2026-08-05 08:06:26",
        "description": "Sakar Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a slight dip in its share price, the stock’s technical indicators present a complex picture, with some signals pointing to sustained strength while others suggest caution for investors."
      },
      {
        "title": "Sakar Healthcare Gains 10.35%: 3 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-gains-1035-3-key-factors-driving-the-weeks-momentum-4131521",
        "imagepath": "",
        "date": "2026-08-01 13:07:44",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Very positive quarterly financial performance announced</p>\n                    <p><strong>28 Jul:</strong> Technical momentum shifts to bullish amid mixed indicators</p>\n                    <p><strong>29 Jul:</strong> Continued price gains with volume support</p>\n                    <p><strong>30 Jul:</strong> Minor pullback amid market consolidation</p>\n                    <p><strong>31 Jul:</strong> Strong finish with 4.84% daily gain closing at ₹885.25</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.802.20</div></div>\n               ..."
      },
      {
        "title": "Sakar Healthcare Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sakar-healthcare-ltd-is-rated-buy-4130099",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SakarHealthcare_mojoScore_4130099.png",
        "date": "2026-07-31 10:11:06",
        "description": "Sakar Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Sakar Healthcare Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-indicators-4123430",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SakarHealthcare_technicaldot_4123430.png",
        "date": "2026-07-28 08:05:18",
        "description": "Sakar Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a mix of technical indicator signals, including MACD, RSI, moving averages, and Bollinger Bands, which collectively suggest an improving price momentum and potential for further upside in the near term."
      },
      {
        "title": "Sakar Healthcare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4121880",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SakarHealthcare_technicaldot_4121880.png",
        "date": "2026-07-27 08:02:49",
        "description": "Sakar Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent day decline of 3.07%, the stock’s year-to-date return of 96.04% significantly outpaces the Sensex’s negative 9.04% return, signalling underlying strength amid mixed technical indicators."
      },
      {
        "title": "Sakar Healthcare Ltd Reports Very Positive Quarterly Financial Performance Amid Margin Expansion",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-ltd-reports-very-positive-quarterly-financial-performance-amid-margin-expansion-4121695",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SakarHealthcare_fintrenddot_4121695.png",
        "date": "2026-07-27 08:00:24",
        "description": "Sakar Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a marked improvement in its financial performance for the quarter ended June 2026. The company’s recent results reveal robust revenue growth, significant margin expansion, and improved return ratios, signalling a very positive shift in its financial trend despite a recent downgrade in its Mojo Grade from Buy to Hold."
      },
      {
        "title": "Are Sakar Healthcare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sakar-healthcare-ltd-latest-results-good-or-bad-4120809",
        "imagepath": "",
        "date": "2026-07-25 19:16:46",
        "description": "Sakar Healthcare Ltd's latest financial results for Q1 FY27 present a complex picture characterized by strong revenue growth but notable margin pressures. The company reported net sales of ₹72.97 crores, reflecting a year-on-year increase of 38.36%, which significantly outpaces the average growth in the pharmaceutical sector. This marks the seventh consecutive quarter of revenue growth, indicating effective market penetration and product portfolio expansion.\n\nHowever, the operational metrics reveal challenges. The net profit for the quarter was ₹10.28 crores, which, while showing a substantial year-on-year growth of 120.13%, represents a sequential decline of 6.72% from the previous quarter. This decline in profitability is further highlighted by the operating margin, which contracted sharply to 29.11% from 36.91% in the prior quarter, indicating potential issues with rising input costs or operational ineff..."
      },
      {
        "title": "Sakar Healthcare Q1 FY27: Strong Growth Momentum Continues Despite Margin Pressure",
        "link": "https://www.marketsmojo.com/news/result-analysis/sakar-healthcare-q1-fy27-strong-growth-momentum-continues-despite-margin-pressure-4119826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SakarHealthcare_quaterlyResult_4119826.png",
        "date": "2026-07-24 18:47:44",
        "description": "Sakar Healthcare Ltd., a Gujarat-based pharmaceutical manufacturer, delivered robust top-line growth in Q1 FY27 with net sales rising 38.36% year-on-year to ₹72.97 crores, though net profit growth of 120.13% to ₹10.28 crores came with a sequential dip of 6.72%. The stock, trading at ₹802.20 with a market capitalisation of ₹1,903 crores, has declined 3.07% following the results announcement, reflecting investor concerns about margin compression despite the strong revenue momentum."
      },
      {
        "title": "Sakar Healthcare Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sakar-healthcare-ltd-is-rated-buy-4109001",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SakarHealthcare_mojoScore_4109001.png",
        "date": "2026-07-20 10:10:41",
        "description": "Sakar Healthcare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 15 May 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 July 2026, providing investors with the most up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 419,
    "sid": "1002668",
    "stock_news_url": "https://www.marketsmojo.com/news/sakar-healthcare-1002668"
  },
  "announcements": [
    {
      "details": "Sakar Healthcare Limitedealthcare Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Sakar Healthcare Limited - Reply to Clarification- Financial results",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Sakar Healthcare Limitede Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Sakar Healthcare Limited - Clarification - Financial Results",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on November 14, 2019.",
      "source": "NSE",
      "caption": "Sakar Healthcare Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sakar Healthcare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-08-05 08:06:26

Sakar Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a slight dip in its share price, the stock’s technical indicators present a complex picture, with some signals pointing to sustained strength while others suggest caution for investors.

Read full news article

Sakar Healthcare Gains 10.35%: 3 Key Factors Driving the Week’s Momentum

2026-08-01 13:07:44

Key Events This Week

27 Jul: Very positive quarterly financial performance announced

28 Jul: Technical momentum shifts to bullish amid mixed indicators

29 Jul: Continued price gains with volume support

30 Jul: Minor pullback amid market consolidation

31 Jul: Strong finish with 4.84% daily gain closing at ₹885.25

Week Open

Rs.802.20

...

Read full news article

Sakar Healthcare Ltd is Rated Buy

2026-07-31 10:11:06

Sakar Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Sakar Healthcare Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators

2026-07-28 08:05:18

Sakar Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a mix of technical indicator signals, including MACD, RSI, moving averages, and Bollinger Bands, which collectively suggest an improving price momentum and potential for further upside in the near term.

Read full news article

Sakar Healthcare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-07-27 08:02:49

Sakar Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent day decline of 3.07%, the stock’s year-to-date return of 96.04% significantly outpaces the Sensex’s negative 9.04% return, signalling underlying strength amid mixed technical indicators.

Read full news article

Sakar Healthcare Ltd Reports Very Positive Quarterly Financial Performance Amid Margin Expansion

2026-07-27 08:00:24

Sakar Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a marked improvement in its financial performance for the quarter ended June 2026. The company’s recent results reveal robust revenue growth, significant margin expansion, and improved return ratios, signalling a very positive shift in its financial trend despite a recent downgrade in its Mojo Grade from Buy to Hold.

Read full news article

Are Sakar Healthcare Ltd latest results good or bad?

2026-07-25 19:16:46

Sakar Healthcare Ltd's latest financial results for Q1 FY27 present a complex picture characterized by strong revenue growth but notable margin pressures. The company reported net sales of ₹72.97 crores, reflecting a year-on-year increase of 38.36%, which significantly outpaces the average growth in the pharmaceutical sector. This marks the seventh consecutive quarter of revenue growth, indicating effective market penetration and product portfolio expansion. However, the operational metrics reveal challenges. The net profit for the quarter was ₹10.28 crores, which, while showing a substantial year-on-year growth of 120.13%, represents a sequential decline of 6.72% from the previous quarter. This decline in profitability is further highlighted by the operating margin, which contracted sharply to 29.11% from 36.91% in the prior quarter, indicating potential issues with rising input costs or operational ineff...

Read full news article

Sakar Healthcare Q1 FY27: Strong Growth Momentum Continues Despite Margin Pressure

2026-07-24 18:47:44

Sakar Healthcare Ltd., a Gujarat-based pharmaceutical manufacturer, delivered robust top-line growth in Q1 FY27 with net sales rising 38.36% year-on-year to ₹72.97 crores, though net profit growth of 120.13% to ₹10.28 crores came with a sequential dip of 6.72%. The stock, trading at ₹802.20 with a market capitalisation of ₹1,903 crores, has declined 3.07% following the results announcement, reflecting investor concerns about margin compression despite the strong revenue momentum.

Read full news article

Sakar Healthcare Ltd is Rated Buy

2026-07-20 10:10:41

Sakar Healthcare Ltd is rated Buy by MarketsMOJO, with this rating last updated on 15 May 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 July 2026, providing investors with the most up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News